Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

47 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza.
Collin N, de Radiguès X; World Health Organization H1N1 Vaccine Task Force. Collin N, et al. Vaccine. 2009 Aug 20;27(38):5184-6. doi: 10.1016/j.vaccine.2009.06.034. Epub 2009 Jun 27. Vaccine. 2009. PMID: 19563891
TRANSVAC research infrastructure - Results and lessons learned from the European network of vaccine research and development.
Geels MJ, Thøgersen RL, Guzman CA, Ho MM, Verreck F, Collin N, Robertson JS, McConkey SJ, Kaufmann SHE, Leroy O. Geels MJ, et al. Among authors: collin n. Vaccine. 2015 Oct 5;33(41):5481-5487. doi: 10.1016/j.vaccine.2015.01.079. Epub 2015 Feb 8. Vaccine. 2015. PMID: 25667962
Technology transfer of an oil-in-water vaccine-adjuvant for strengthening pandemic influenza preparedness in Indonesia.
Ventura R, Brunner L, Heriyanto B, de Boer O, O'Hara M, Huynh C, Suhardono M, Collin N. Ventura R, et al. Among authors: collin n. Vaccine. 2013 Mar 15;31(12):1641-5. doi: 10.1016/j.vaccine.2012.07.074. Epub 2012 Aug 8. Vaccine. 2013. PMID: 22884665
The Vaccine Formulation Laboratory: a platform for access to adjuvants.
Collin N, Dubois PM. Collin N, et al. Vaccine. 2011 Jul 1;29 Suppl 1:A37-9. doi: 10.1016/j.vaccine.2011.04.125. Vaccine. 2011. PMID: 21684427 Review.
[Influenza vaccine: globalization of public health stakes].
Collin N, Briand S. Collin N, et al. Med Trop (Mars). 2009 Aug;69(4):322. Med Trop (Mars). 2009. PMID: 19725377 French.
Antigen sparing with adjuvanted inactivated polio vaccine based on Sabin strains.
Westdijk J, Koedam P, Barro M, Steil BP, Collin N, Vedvick TS, Bakker WA, van der Ley P, Kersten G. Westdijk J, et al. Among authors: collin n. Vaccine. 2013 Feb 18;31(9):1298-304. doi: 10.1016/j.vaccine.2012.12.076. Epub 2013 Jan 9. Vaccine. 2013. PMID: 23313617 Free PMC article.
Accounting for adjuvant-induced artifacts in the characterization of vaccine formulations by polyacrylamide gel electrophoresis.
Jakob V, Brunner L, Barnier-Quer C, Blust M, Collin N, Carter L, Carter D, Rausch KM, Fox CB. Jakob V, et al. Among authors: collin n. Ther Adv Vaccines. 2017 Apr;5(2):31-38. doi: 10.1177/2051013617702072. Epub 2017 May 3. Ther Adv Vaccines. 2017. PMID: 28515938 Free PMC article.
Modern Vaccines/Adjuvants Formulation--Session 2 (Plenary II): May 15-17, 2013--Lausanne, Switzerland.
Collin N. Collin N. Hum Vaccin Immunother. 2013 Sep;9(9):2015-6. doi: 10.4161/hv.26208. Epub 2013 Aug 20. Hum Vaccin Immunother. 2013. PMID: 23966098 Free PMC article.
Electroporation of a nanoparticle-associated DNA vaccine induces higher inflammation and immunity compared to its delivery with microneedle patches in pigs.
Bernelin-Cottet C, Urien C, McCaffrey J, Collins D, Donadei A, McDaid D, Jakob V, Barnier-Quer C, Collin N, Bouguyon E, Bordet E, Barc C, Boulesteix O, Leplat JJ, Blanc F, Contreras V, Bertho N, Moore AC, Schwartz-Cornil I. Bernelin-Cottet C, et al. Among authors: collin n. J Control Release. 2019 Aug 28;308:14-28. doi: 10.1016/j.jconrel.2019.06.041. Epub 2019 Jun 29. J Control Release. 2019. PMID: 31265882 Free article.
Systems Immunology Characterization of Novel Vaccine Formulations for Mycoplasma hyopneumoniae Bacterins.
Matthijs AMF, Auray G, Jakob V, García-Nicolás O, Braun RO, Keller I, Bruggman R, Devriendt B, Boyen F, Guzman CA, Michiels A, Haesebrouck F, Collin N, Barnier-Quer C, Maes D, Summerfield A. Matthijs AMF, et al. Among authors: collin n. Front Immunol. 2019 May 24;10:1087. doi: 10.3389/fimmu.2019.01087. eCollection 2019. Front Immunol. 2019. PMID: 31178860 Free PMC article.
47 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page